BackAspire Biopharma Holdings Overview

Aspire Biopharma Holdings Profit Margin

Aspire Biopharma Holdings (ASBPW) has a profit margin of -11314.46%, below the sector sector average of 13.23%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-2009.61%

As of Jun 2026

Annual Profit Margin (TTM)

-11314.46%

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Aspire Biopharma Holdings (ASBPW) FAQ

The latest profit margin for ASBPW is -11314.46% as of June 2026. That is below the sector sector average of 13.23%. Investors often review this figure alongside Aspire Biopharma Holdings's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, ASBPW currently prints -11314.46% for profit margin, while the sector average sits near 13.23%. That is roughly 85646.2% below the sector mean. Large gaps often invite a closer look at Aspire Biopharma Holdings's growth, margins, and balance sheet.

Profit Margin shows how effectively Aspire Biopharma Holdings converts resources into returns. At -11314.46%, ASBPW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ASBPW's profit margin (-11314.46%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.